Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.
Ahimbisibwe G, Greenwood D, Wilkinson KA, Gahir J, Townsley H, Miah M, Bawumia P, Chaloner C, Levi D, Hobson P, Riddell A, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Daley O, Bazire J, Harvey R, Fowler AS, Smith C, Miranda M, O'Reilly N, Warchal S, Ambrose K, Strange A, Kelly G, Kjar S; Legacy Investigators; Williams B, Libri V, Gamblin S, Gandhi S, Swanton C, Bauer DL, Wilkinson RJ, Carr EJ, Wall EC. Ahimbisibwe G, et al. J Infect. 2025 Sep;91(3):106598. doi: 10.1016/j.jinf.2025.106598. Epub 2025 Aug 21. J Infect. 2025. PMID: 40848990 Free PMC article.
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024.
Stevenson-Leggett P, Adams L, Greenwood D, Lofts A, Libri V, Williams B, Gandhi S, Swanton C, Gamblin S, Carr EJ, Harvey R, Lewis NS, Wu MY, Wall EC; Crick Neutralization Consortium; Legacy Investigators; Crick Neutralization Consortium and Legacy Investigators. Stevenson-Leggett P, et al. Emerg Infect Dis. 2025 Jun;31(6):1202-1206. doi: 10.3201/eid3106.241796. Emerg Infect Dis. 2025. PMID: 40439507 Free PMC article.
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
Shawe-Taylor M, Greenwood D, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Bazire J, Harvey R; Crick COVID Serology Pipeline Investigators, Legacy Investigators; Libri V, Kassiotis G, Gamblin S, Lewis NS, Williams B, Swanton C, Gandhi S, Carr EJ, Wu MY, Bauer DLV, Wall EC. Shawe-Taylor M, et al. Lancet. 2024 Mar 23;403(10432):1133-1136. doi: 10.1016/S0140-6736(24)00316-7. Epub 2024 Mar 11. Lancet. 2024. PMID: 38484752 Free PMC article. No abstract available.
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
Dowgier G, Hobbs A, Greenwood D, Shawe-Taylor M, Stevenson-Leggett P, Bazire J, Penn R, Harvey R; Crick COVID serology pipeline, Legacy Investigators; Libri V, Kassiotis G, Gamblin S, Lewis NS, Williams B, Swanton C, Gandhi S, Bauer DLV, Carr EJ, Wall EC, Wu MY. Dowgier G, et al. Vaccine. 2025 Apr 30;54:126960. doi: 10.1016/j.vaccine.2025.126960. Epub 2025 Mar 7. Vaccine. 2025. PMID: 40056806 Free article.
SARS-CoV-2 antibody immunity across three continents: the West Africa, West Indies, West London Consortium.
Greenwood D, Hague O, Kwesi-Maliepaard EM, Redman SA; Crick Serology Consortium; HERITAGE study team; Legacy Investigators; WINDFall Study Team; WWW Consortium Team; Scott F, Anzinger JJ, Awandare G, Bauer DL, Bediako Y, Carr EJ, Carrington CV, Kucharski A, Quashie P, Wall EC, Wu MY. Greenwood D, et al. medRxiv [Preprint]. 2025 Jun 14:2025.06.13.25329588. doi: 10.1101/2025.06.13.25329588. medRxiv. 2025. PMID: 40585115 Free PMC article. Preprint.